Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT00220740 · COMPLETED
Trial details
- NCT number
- NCT00220740
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-06-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.